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Abstract
Aims: Cystathionine b-synthase (CBS) catalyzes the first and rate-limiting step in the two-step trans-sulfuration
pathway that converts homocysteine to cysteine. It is also one of three major enzymes responsible for the
biogenesis of H2S, a signaling molecule. We have previously demonstrated that CBS is activated in cells
challenged by oxidative stress, but the underlying molecular mechanism of this regulation has remained
unclear. Results: Here, we demonstrate that S-glutathionylation of CBS enhances its activity*2-fold in vitro.
Loss of this post-translational modification in the presence of dithiothreitol results in reversal to basal activity.
Cys346 was identified as the site for S-glutathionylation by a combination of mass spectrometric, mutagenesis,
and activity analyses. To test the physiological relevance of S-glutathionylation-dependent regulation of CBS,
HEK293 cells were oxidatively challenged with peroxide, which is known to enhance the trans-sulfuration flux.
Under these conditions, CBS glutathionylation levels increased and were correlated with a*3-fold increase in
CBS activity. Innovation: Collectively, our results reveal a novel post-translational modification of CBS, that
is, glutathionylation, which functions as an allosteric activator under oxidative stress conditions permitting
enhanced synthesis of both cysteine and H2S. Conclusions: Our study elucidates a molecular mechanism for
increased cysteine and therefore glutathione, synthesis via glutathionylation of CBS. They also demonstrate the
potential for increased H2S production under oxidative stress conditions, particularly in tissues where CBS is a
major source of H2S. Antioxid. Redox Signal. 22, 350–361.
Introduction
Cystathionine b-synthase (CBS) is a pyridoxal 5¢-phosphate (PLP)-dependent hemeprotein (2, 33) which
catalyzes the first steps in the trans-sulfuration pathway that
converts homocysteine to cysteine, the limiting reagent in
the synthesis of the antioxidant, glutathione (GSH). Alter-
natively, CBS can catalyze the condensation of cysteine and
homocysteine or the condensation of twomoles of cysteine to
produce hydrogen sulfide (H2S) (6, 45), a signaling molecule
with cytoprotective effects (19–21, 24). Mutations in CBS
represent the single most common cause of severe heredi-
tary hyperhomocysteinemia and lead to a number of com-
plications affecting the cardiovascular, ocular, skeletal, and
central nervous systems (26).
Human CBS is a modular protein comprising three func-
tional domains (50). The N-terminal domain binds the heme
cofactor, which functions as an allosteric regulator (44), in-
hibiting CBS activity in response to binding of CO or NO (3,
47) or during reduction of nitrite (14). Nitration of tryptophan
Innovation
The flux of sulfur to cysteine, the limiting reagent for
glutathione biogenesis, increases under oxidative stress
conditions and serves to replenish depleted glutathione
levels. We demonstrate that glutathionylation of human
cystathionine b-synthase under oxidizing conditions in-
creases its activity, thereby supporting increased cysteine
synthesis.
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residues in CBS by peroxynitrite results in alterations in the
heme pocket, leading to loss of cysteinate coordination by the
heme ligand Cys52 and concomitant inactivation of CBS (5).
While a structural role for the heme in stabilizing the CBS
structure has been invoked (29), homologousCBSs from lower
organisms, for example, yeast, are stable without this cofactor
(18). The central catalytic domain of CBS contains the PLP
cofactor essential for catalysis and a CXXC motif, whose
function, if any, has yet to be determined (30, 48). The C-
terminal regulatory domain contains a tandem repeat of ‘‘CBS
domains’’ that bind S-adenosylmethionine (AdoMet), an allo-
steric activator (11, 39). The regulatory domain can be cleaved
to yield a truncated dimeric enzyme, which is more active than
the full-length enzyme but unresponsive to AdoMet (23).
The trans-sulfuration pathway is a quantitatively signifi-
cant route for cysteine, the limiting substrate for GSH syn-
thesis (36). GSH is an abundant antioxidant in mammalian
cells and plays an important role in intracellular redox ho-
meostasis and in cellular defense against xenobiotic stress
(27). It is, therefore, not surprising that a number of enzymes
in the sulfur metabolic nexus display sensitivity to redox
changes. Indeed, metabolic labeling studies have revealed
that flux through the trans-sulfuration pathway is increased in
response to oxidative stress (36). Thus, a threefold increase in
the level of cystathionine formation catalyzed by CBS was
observed when HepG2 cells were exposed to 200lM tertiary
butyl hydroperoxide (tBuOOH).
Since CBS is the committing enzyme in the trans-
sulfuration pathway, we focused on it as a locus for potential
regulation in response to exogenous oxidants. However,
since no changes were seen in CBS protein levels in oxida-
tively challenged cells (36), we hypothesized that the activity
of CBS might be regulated in response to oxidative stress via
reversible post-translational modification of one or more
cysteine residues. Human CBS has 11 cysteine residues, in-
cluding two in the CXXCmotif, which have been observed in
the oxidized disulfide and reduced dithiol states (30, 48) and
were the initial focus of our study to elucidate how the ac-
tivity of CBS is upregulated under oxidative conditions.
However, as reported here, our studies led us to the unex-
pected discovery that the activity of CBS is regulated via
glutathionylation, which occurs at a cysteine residue that does
not reside within the CXXC motif. We demonstrate that glu-
tathionylation of CBS results in an *2-fold increase in en-
zyme activity in vitro. Furthermore, glutathionylation of CBS
is also observed in cultured cells subjected to oxidative stress
and is correlated with an *3-fold increase in CBS activity.
These results suggest a model for an auto-corrective cellular
response to GSH pools compromised under oxidative stress
conditions via glutathionylation of CBS, which increases flux
through the trans-sulfuration pathway, thereby increasing
availability of cysteine, the limiting reagent for GSH synthesis.
Results
CBS is S-glutathionylated in vitro
To test whether CBS can be glutathionylated, the protein
was initially treated with dithiothreitol (DTT) to reduce all
accessible cysteines to thiols. After removal of DTT, we then
determined the effect of different concentrations of diamide
on glutathionylation of CBS. For this, the GSH concentration
was fixed at 1mM and the diamide concentrations were
FIG. 1. S-glutathionylation of CBS in vitro and its effect on activity. (a) Purified recombinant CBS (0.5mg/ml) was
incubated with 1mM DA and 1.5mM GSH followed by treatment with 10mM DTT in indicated samples as described under
the ‘‘Materials and Methods’’ section. The protein samples (25 ng) were separated by nonreducing SDS-PAGE followed by
Western blot analysis using anti-SSG antibody (top) or anti-CBS antibody (bottom). Molecular masses of protein standards
in kDa are shown on the left. The data are representative of at least three independent experiments. IB denotes immuno-
blotting with either the anti-glutathione (anti-SSG) or anti-CBS antibody. (b) Effect of glutathionylation on CBS activity.
Recombinant wild-type CBS (0.5mg/ml) was incubated with 1mM DA and 1.5mM GSH, followed by 10mM DTT as
indicated, and then the samples were dialyzed to remove DA, GSH, and DTT. CBS activity was measured using me-
thylcysteine (10mM) as a substrate in the 100mM HEPES buffer, pH 7 .4. The graph represents the relative activity of
samples compared with untreated controls and is the mean – SD (n = 3), **p < 0.01 versus control. The specific activity of
the control sample in the methylcysteine assay (using DTNB detection) was 2.0 – 0.1 lmol methanethiol h- 1 mg protein - 1.
CBS, cystathionine b-synthase; DA, diamide; DTNB, 5,5¢-dithiobis-2-nitrobenzoic acid; DTT, dithiothreitol; GSH, gluta-
thione; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
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varied from 0 to 1mM. The minimum diamide concentration
that was required for glutathionylation detectable byWestern
blot analysis was 0.7mM (Supplementary Fig. S1; Supple-
mentary Data are available online at www.liebertpub.com/
ars). Hence, in subsequent experiments, CBS was oxidized
with 1mM diamide and then treated with an excess of GSH
(1.5mM) to oxidize exposed cysteines and to subsequently
glutathionylate one or more susceptible thiols. Formation of
S-glutathionylated CBS was detected by Western blot anal-
ysis using an anti-SSG antibody (Fig. 1a, top panel). Two
bands cross-reacted with the anti-SSG antibody and corre-
sponded to the CBS monomer and dimer with molecular
masses of*63 and*130 kDa, respectively (lane 4). Addition
of DTT to the glutathionylated sample resulted in loss of the
cross-reacting bands, which is consistent with reduction of the
mixed disulfide bond between GSH and CBS (lane 5). Dia-
mide treatment of CBS led to intersubunit cross-linking and in
Western blots using CBS antibody (Fig. 1a, lower panel),
bands corresponding to the monomeric, dimeric, and multi-
meric (> 250 kDa) species were observed (lanes 3 and 4),
which were resolved into the monomeric species only on DTT
treatment (lane 5). S-glutathionylation was not observed in
control samples in which CBS was treated with diamide or
GSH alone (top panel, lanes 2 and 3).
Proportion of CBS that is glutathionylated
Native CBS has 11 cysteine residues, and the number of
accessible thiols was determined using Ellman’s reagent
(5,5¢-dithiobis-2-nitrobenzoic acid [DTNB]). A total of 4.7 –
0.3 cysteines were modified per CBS monomer and the
number decreased to 3.5 – 0.25 after diamide (1mM) +GSH
(1.5mM) treatment. This result indicated that one of the five
accessible cysteines in the untreated sample was oxidized
and/or modified after diamide +GSH treatment. Previously,
two cysteines, Cys15 and Cys431 in the heme and regulatory
domains, respectively were reported to be solvent accessible
in CBS, using the DTNB assay (12). The basis for the dis-
crepancy between these two data sets is not known but could
result from differences in handling of proteins samples given
the propensity of full-length CBS to aggregate (41). To de-
termine what proportion of the protein was glutathionylated,
untreated and diamide-oxidized CBS were treated with bio-
tinylated glutathione ethyl ester (BioGEE). Approximately
80% – 4% of the protein was retained on the streptavidin-
agarose resin corresponding to the proportion of protein that
was glutathionylated.
FIG. 2. Effect of GSSG on CBS. (a) S-glutathionylation was carried out by treating CBS [0.5mg/ml with 1mM DA/
1.5mM GSH (lane 2), 1mM GSSG (lane 3), 2mM GSSG (lane 4), or 5mM GSSG (lane 5) followed by nonreducing SDS-
PAGE and Western blot analysis] with anti-SSG antibody (top) or anti-CBS antibody (bottom). (b) Effect of GSSG on CBS
activity. CBS (0.5mg/ml) was incubated with the indicated concentrations of GSSG for 1 h at room temperature, and then
the samples were dialyzed to remove GSSG. CBS activity was measured using the methylcysteine assay. The graph
represents the treated compared with untreated controls and is the average – SD (n= 3). GSSG, glutathione disulfide.
FIG. 3. S-glutathionylation of H2O2-oxidized CBS and
its effect on activity. Recombinant wild-type CBS (0.5mg/
ml) was incubated with different concentrations of H2O2 and
GSH, followed by 10mM DTT treatment as indicated. The
samples were then dialyzed, and CBS activity was measured
using the methylcysteine assay as described in Figure 1
legend. The data represent the activity of samples compared
with untreated controls and are the average – SD (n = 3),
*p < 0.05 or **p < 0.01 versus control.
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Glutathionylation increases CBS activity
We next investigated the effect of glutathionylation on
CBS activity. The standard in vitro assay for CBS is not
suitable for measuring the activity of glutathionylated CBS,
as homocysteine is used as a substrate and can reduce the
mixed disulfide between GSH and CBS. Hence, we used a
modified assay in which S-methylcysteine is employed as a
substrate. The product of this reaction is methanethiol, which
is detected by UV-visible absorption or fluorescence spec-
troscopy after treatment with DTNB or Thiostar, respec-
tively. Glutathionylation increased the activity of CBS to
226% – 15% compared with untreated control samples (Fig.
1b). Interestingly, glutathionylated CBS was not further ac-
tivated in the presence of 1mM AdoMet, an allosteric acti-
vator. Unexpectedly, diamide alone (1mM) also increased
the activity of CBS to 149% – 2% of the control value. Ad-
dition of DTT (10mM) partially reversed the activity of
glutathionylated CBS to 157% – 12% of the control value.
However, the basal activity level was not completely re-
covered.
We next determined whether the physiologically relevant
oxidants glutathione disulfide (GSSG) or H2O2 activate CBS.
Under oxidative stress conditions, the GSSG pool size
increases and this can promote protein glutathionylation.
Treatment of reduced CBS with 1–5mM GSSG showed
increasing glutathionylation of the CBS monomer but not
of the cross-linked dimer as observed with diamide +GSH
(Fig. 2a). However, CBS treated with GSSG did not show a
detectable change in activity even in the presence of 5mM
GSSG (Fig. 2b), suggesting that the proportion of glutathio-
nylation with this reagent was significantly lower than that
FIG. 4. Mass spectro-
scopic identification of the
glutathionylation site in
CBS. CBS (100 lM) was
treated with – 2mM diamide
and 3mM GSH for 30min at
room temperature and then
denatured with 6 M guani-
dine hydrochloride. Free
thiol groups were derivatized
with 10mM iodoacetamide,
followed by tryptic digestion
for LC-MS/MS analysis. Mass
spectra of a peptide from
untreated (a) and glutathio-
nylated (b) CBS are com-
pared. Triple-charged masses
(M+ 3H)3 + of the glutathio-
nylated and iodoacetamide-
derivatized peptide (MLIAQ
EGLLCGGSAGSTVAVAVK)
are 827.41 or 744.73 Da, re-
spectively. The data are rep-
resentative of three independent
experiments. (c) Traces show-
ing that the glutathionylated
CBS peak (827.41 Da) is
unique for diamide/GSH-
treated samples (lower trace)
and not seen in the control
DTT-treated sample (upper
trace). LC-MS/MS, liquid
chromatography–tandem mass
spectrometry.
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observed with GSH. This was confirmed by thiol quantitation
of CBS treated with 2mM GSSG, which revealed that
4.8 – 0.35 cysteines were reduced and accessible for modifi-
cation by DTNB, which is identical to the value obtained in
the untreated control (4.7 – 0.3). Hence, the high sensitivity
of the Western blot method enables detection of the very low
proportion of CBS that is glutathionylated in the presence of
GSSG.
In contrast to GSSG treatment, the activity of CBS in-
creased when treated with different concentrations of H2O2
(10–200 lM) for 30min and then exposed to GSH, peaking
at 25lM H2O2, where the activity was 159% – 11% of the
control value (Fig. 3). Beyond this concentration of H2O2, the
activity of CBS decreased. Unlike diamide treatment, which
only results in formation of disulfide bonds, treatment with
H2O2 can generate sulfeninc, sulfinic, and sulfonic acids in
addition to disulfides. Of these, the overoxidized sulfinic and
sulfonic acids cannot be modified by GSH. Hence, the pro-
portion of glutathionylated CBS is expected to be lower in
H2O2 versus diamide-treated samples. To test this possibility,
the extent of BioGEE modification of H2O2-oxidized CBS
samples was determined after affinity purification using a
streptavidin column. In comparison to the 80%– 4% modi-
fication observed in diamide-treated samples, 64%– 3% of
CBS was glutathionylated in H2O2-treated samples. Treat-
ment of CBSwith 25lMH2O2 alone did not affect its activity
and in the presence of 10mM DTT, basal CBS activity was
fully recovered (Fig. 3).
CBS is glutathionylated at Cys346
The site(s) of glutathionylation on CBS were identified
by liquid chromatography–tandem mass spectrometry (LC-
MS/MS) after tryptic digestion of glutathionylated CBS
(generated in the presence of diamide +GSH) (Fig. 4 and
Supplementary Fig. S2). Before trypsin digestion, CBS was
denatured and the free thiol groups were blocked with io-
doacetamide. The experiment was repeated thrice, and
MS analysis identified a single modified peptide (MLIA-
QEGLLCGGSAGSTVAVAVK) and Cys346 as the site of
glutathionylation (Fig. 4). The difference in the monoisotopic
masses of the triply charged glutathionylated (827.41 Da) and
control iodoacetamide-derivatized (744.73 Da) peptides is
248.04 Da (3 · 82.68 Da), which corresponds to the expected
mass difference between GSH (306.09 Da) and iodoaceta-
mide (58.05 Da) modification of the cysteine residue. The
modified M337-K359 peptide had an observed molecular
mass of 2479.21 Da in excellent agreement with a mass of
2479.23 Da calculated for the presence of a single glutathi-
one-Cys346 mixed disulfide.
Mutation of Cys346 leads to loss of glutathionylation
To validate Cys346 as the site of glutathioylation in CBS,
we generated the Cys346Ser mutant. The purity of the mutant
CBS was judged to be >90% by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) analysis
FIG. 5. Mutation of Cys346 abolishes glutathionylation
of CBS. (a) Wild-type and Cys346Ser CBS were treated
with 1mM DA and 1.5mM GSH for 30min at room tem-
perature, subjected to nonreducing SDS-PAGE followed by
immunoblotting with anti-SSG antibody (top) or anti-CBS
antibody (bottom). The CBS monomer (63 kDa) and a di-
meric species were detected with anti-SSG antibody in the
DA +GSH-treated wild type but not in Cys346Ser CBS. In
contrast, anti-CBS antibody was observed in both the mo-
nomeric and cross-linked dimeric species in samples that
were oxidized with DA. Wild-type and Cys346Ser CBS
were treated with – 1mM DA and 1.5mM GSH for 30min at
room temperature (b) or with – 25lM H2O2 for 30min
followed by 125 lM GSH (c). The samples were then dia-
lyzed, and CBS activity was measured using the methyl-
cysteine assay as described in Figure 1 legend. *p < 0.05 or
**p < 0.01 versus controls. N.S., not significant.
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and comparable to that of the wild-type protein (not shown).
However, the yield of the purified Cys346Ser mutant
(*1.0mg/L of culture) was*7-fold lower than that of wild-
type CBS. The activities of the wild-type and mutant
Cys346Ser CBS were assessed in 100mM HEPES buffer pH
7.4, and in the presence or absence of 1mM AdoMet using
the standard radioactive and lead acetate assays as described
under the ‘‘Materials and Methods’’ section. The basal ac-
tivity of Cys346Ser CBSwas*1.3-fold lower than wild-type
CBS in both assays.
We next determined the effect of the Cys346Ser mutation
on glutathionylation of CBS by Western blot analysis. In
contrast to wild-type CBS, which exhibited strong signal
intensity due to glutathionylation, this modification was not
observed with the Cys346Ser mutant (Fig. 5a). Unlike wild-
type CBS, no change in Cys346Ser CBS activity was ob-
served before and after treatment with diamide +GSH (Fig.
5b). Similarly, pretreatment with 25lM H2O2 followed by
GSH did not affect the activity of the mutant CBS (Fig. 5c).
Collectively, these results are consistent with Cys346 being
the site of glutathionylation, which is correlated with in-
creased CBS activity.
In addition to Cys346, we also mutated the residues in
the CXXC motif to generate the double mutant, Cys272Ala/
Cys275Ser. Similar to wild-type CBS, the activity of
the double mutant was increased by treatment with di-
amide +GSH (data not shown). These data rule out the cys-
teines in the CXXC motif as sites for glutathionylation and
are consistent with the mass spectrometric data.
H2O2 induces S-glutathionylation of CBS in cultured
cells and enhances CBS activity
To assess the physiological relevance of CBS glutathio-
nylation, we examined whether this modification is observed
in cells and is responsive to oxidative stress conditions in-
duced by H2O2 treatment. For this, HEK293 cells were in-
cubated with 250 lMBioGEE for 1 h, followed by 10, 30, and
60min exposure to H2O2 (200 lM) as described in the
‘‘Materials and Methods’’ section. While 100 lM H2O2 is
unlikely to be physiologically relevant, such concentrations
have been previously used and are necessary to observe de-
tectable changes in metabolite pools (36). Incorporation
of BioGEE into CBS enables it to be pulled down by
streptavidin-agarose beads, followed by detection of the
modification by Western blot analysis using CBS antibodies.
Exposure to 200lM H2O2 induced a significant increase in
glutathionylated CBS within 10min (Fig. 6a). Prolonged
exposure to H2O2 resulted in a gradual decline in the CBS
glutathionylation level. After 60min of H2O2 exposure, the
level of glutathionylated CBS was similar to that seen in
untreated cells (Fig. 6a, lanes 2 and 5). In the absence of
BioGEE treatment, glutathionylation of CBS could not be
detected as expected (lane 1). The dimeric form of CBS seen
under in vitro conditions using the strong oxidant, diamide,
was not seen in the cell culture experiments (data not shown).
These results indicate that a low level of CBS glutathiony-
lation exists under steady-state conditions and that it in-
creases transiently and rapidly after an oxidative challenge.
The activity of CBS was also measured in HEK293 cell
lysates from control and H2O2-treated cultures. Since both
CBS and cystathionine-c-lyase (CSE) can, in principle, uti-
lize methylcysteine to produce methanethiol, a suicide in-
activator of CSE, propargylglycine (PPG) (1) was added to
the reaction mixture. Formation of methanethiol was moni-
tored by gas chromatography coupled to a sulfur chemilu-
minescence detector as described under the ‘‘Materials and
Methods’’ section. CBS activity increased to 317% – 48% of
the control value when cells were incubated with 200 lM
H2O2 for 10min (Fig. 6b). Increasing exposure to H2O2
(30 and 60min) resulted in a gradual decrease in CBS ac-
tivity to 199% – 34% and 140% – 9% of the control value,
respectively, which is qualitatively similar to the results from
theWestern blot analysis (Fig. 6a). These results are consistent
with a transient increase in glutathionylation and activation of
CBS under oxidative stress conditions in HEK293 cells.
Discussion
GSH is an abundant peptide antioxidant that is maintained
at concentrations varying from *1 to 10mM depending
on the cell type. Its synthesis is limited by cysteine, and the
rate-limiting enzyme in the GSH synthesis pathway is c-
glutamylcysteine ligase (Fig. 7). The trans-sulfuration
FIG. 6. Oxidative stress increases CBS S-glutathiony-
lation and activity in HEK293 cells. (a) HEK293 cells
were preincubated – 250 lM BioGEE for 1 h and subse-
quently exposed to 200lM H2O2 for 10, 30, and 60min.
Biotin-bound proteins were extracted using streptavidin af-
finity resin and eluted with 10mM DTT. The eluents (top)
and whole cell extracts (10 lg protein/lane) were subjected
to nonreducing SDS-PAGE and probed with anti-CBS an-
tibody. (b) Cell lysates from HEK293 cells exposed to
200lM H2O2 for 10, 30, and 60min were used to assay for
CBS activity using methylcysteine in the presence of the
CSE inhibitor, 2.5mM PPG. CH3SH production was mea-
sured by gas chromatography coupled to a sulfur chemilu-
minescence detector as described under the ‘‘Materials and
Methods’’ section. The data are representative of at least
three independent experiments. *p < 0.05 or **p < 0.01
versus control. BioGEE, biotinylated glutathione ethyl ester;
CSE, cystathionine-c-lyase; PPG, propargylglycine.
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pathway is an important determinant of intracellular cysteine
concentration and accounts for *40%–50% of the cysteine
that is tied up in the GSH pool in some cell types (36, 54). An
important role of GSH is the removal of H2O2 catalyzed
by GSH peroxidase. The product of the reaction is GSSG,
which builds up initially under oxidative stress conditions,
thus diminishing the GSH pool size (Fig. 7). The cellular
autocorrective response for normalizing GSH levels under
these conditions includes upregulation of c-glutamylcysteine
ligase (42, 43, 56) and as we had previously shown, in-
creased trans-sulfuration flux (36). While regulation of c-
glutamylcysteine ligase occurs at the transcriptional level
(34, 35, 37), the mechanism of increased trans-sulfuration
flux was not known. Upregulation of the trans-sulfuration
flux is expected to involve CBS, which catalyzes the rate-
limiting step in the two-step pathway. Since Western blot
analysis had revealed that CBS protein levels were un-
changed in cell lysates from oxidatively challenged cells
versus untreated controls, a post-translational mechanism for
upregulation of the trans-sulfuration flux was implicated
(36). In this study, we report that S-glutathionylation of CBS
represents a mechanism for enhancing CBS activity under
oxidative stress conditions.
S-glutathionylation is a reversible post-translational
modification of proteins, which is important in redox sig-
naling and metabolism, cytoskeletal assembly, and ion ho-
meostasis (8, 9, 32, 51). Glutathionylation frequently inhibits
enzyme activity by targeting an active site cysteine; for ex-
ample, in protein tyrosine phosphatase 1B (38) and caspase 3
(17) or a cysteine that impedes access to the active site, for
instance, in methionine synthase (16). In contrast, CBS is
glutathionylated at Cys346 and this modification activates
the enzyme. The mechanism of allosteric activation of CBS
by glutathionylation warrants further elucidation. Allosteric
modulation by glutathionylation has also been described in
thioredoxin, where modification of a cysteine residue that is
not in the catalytic CXXC motif results in inhibition of its
oxidoreductase activity (4, 31).
Both surface exposure and perturbation of the thiol pKa to
lower values are important predictors of the glutathionylation
propensity of cysteines in protein structures (46). Typically,
electrostatic stabilization of the thiolate anion with positively
charged residues in the vicinity enhances the reactivity of
cysteines. However, exceptions to these generalizations are
known to exist, for example, in cyclophilin A, where the site
of glutathionylation is not the cysteine whose side chain
exhibits the greatest accessible surface area (15). The struc-
ture of full-length human CBS (10) reveals that Cys346 is
located near the dimer interface in a hydrophobic pocket and
is not particularly well exposed (Fig. 8). Since glutathiony-
lation is only detected at Cys346 (Fig. 4) and lost on its
mutagenesis to serine (Fig. 5), protein dynamics could allow
access to this reactive cysteine residue. Alternatively, in the
cell, glutathionylation of CBS might be catalyzed, for
FIG. 7. Model for CBS glutathionylation-dependent
increase in the trans-sulfuration flux and H2S production
under oxidative stress conditions. (a) The trans-sulfuration
enzymes, CBS and CSE also produce H2S from cysteine and
homocysteine. Under oxidative stress conditions (denoted
by gray block arrows), GSH levels are initially decreased by
increased oxidation of GSH, for example, by GP. Under
these conditions, glutathionylation of CBS increases its ac-
tivity, leading to increased cysteine and H2S production.
Cysteine is the limiting substrate for GSH synthesis cata-
lyzed by GCL and GS. Increased trans-sulfuration flux leads
to restoration of the GSH pool compromised under oxidative
stress conditions. GR denotes glutaredoxin. (b) A potential
mechanism for glutathionylation of CBS. Under oxidative stress
conditions, Cys346 in CBS is oxidized to a sulfenic acid, which
is then modified by gluthionylation, which could be catalyzed,
for example, by glutaredoxin. GCL, c-glutamylcysteine ligase;
GP, glutathione peroxidase; GS, GSH synthetase.
FIG. 8. Location of Cys346 in the crystal structure of
full-length human CBS. The two subunits of CBS are
shown in purple and green, respectively, and the cofactors,
PLP and heme, are shown in ball representation. Cys346,
also shown in ball representation, is close to the dimeric
interface. The figure was made using PDB file 4L28. PLP,
pyridoxal 5¢-phosphate. To see this illustration in color, the
reader is referred to the web version of this article at
www.liebertpub.com/ars
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example, by glutaredoxin, which could increase exposure of
Cys346 in the inter-protein complex. The relatively buried
position of Cys346 might explain why GSSG, which is twice
the size of GSH, is unable to modify it efficiently to impact
activity under in vitro conditions (Fig. 2). In cells exposed to
H2O2, glutathionylation of CBS increased transiently before
returning to steady-state levels (Fig. 6).
Since glutathionylation of CBS is efficient with GSH but
not with GSSG, it implies that the thiol of Cys346 should first
be oxidized, for example, to a sulfenic acid before being
attacked by GSH (Fig. 7b). Hence, Cys346 could function
as a redox sensor with its proportion increasing with in-
creasing concentrations of reactive oxygen species under
conditions of cellular oxidative stress, which, in turn, sets up
S-glutathionylation of CBS. In cells exposed to oxidative
challenge, glutathionylation of CBS increased transiently
before returning to low steady-state levels and was correlated
with an *3-fold increase in CBS activity in cell lysates
(Fig. 6). It is not known whether or not deglutathionylation
of CBS is catalyzed, and this issue needs to be investigated.
The expected consequence of CBS glutathionylation is in-
creased synthesis of cysteine, the product of the canonical
trans-sulfuration pathway. This model is supported by the
previously observed increase in the trans-sulfuration flux as
evidenced by increased synthesis of cystathionine (and sub-
sequently GSH) in cells challenged with H2O2 (36). The
combined effect of upregulation of the rate-limiting en-
zymes in the trans-sulfuration and GSH synthesis pathways
via glutathionylation of CBS and increased synthesis of c-
glutamylcysteine ligase (42, 43, 56), respectively, is resto-
ration of the GSH pool size, which is initially depleted under
oxidative stress conditions.
A second predicted consequence of CBS glutathionylation
is the increased production of H2S. In this study, we have
employed S-methylcysteine a substrate analog of cysteine, to
monitor the effect of glutathionylation on CBS activity. The
product of this reaction is methanethiol, an H2S surrogate.
Our study demonstrates that glutathionylation increases
methanethiol production by CBS, indicating that H2S pro-
duction is predicted to increase both as a consequence of
enhanced CBS activity and greater availability of the H2S
substrate, cysteine. H2S is a signaling molecule that is gen-
erated by at least three enzymes, CBS, CSE, and mercapto-
pyruvate sulfurtransferase, whose relative contributions vary
in a tissue-specific manner. In tissues such as the brain, where
CBS is dominant, enhanced H2S production might be a sig-
nificant outcome of oxidative stress-induced glutathionyla-
tion. H2S has been shown to protect against oxidative stress in
brain cells (25, 52) and in HUVECs (55).
In summary, we report a new post-translational modifica-
tion of CBS that provides a molecular explanation for the old
observation that trans-sulfuration flux is increased under oxi-
dative stress conditions (36). The study also demonstrates the
potential to increase H2S production under oxidizing condi-
tions via S-glutathionylation of CBS. However, the physio-
logical effects of enhanced H2S remain to be fully elucidated.
Materials and Methods
Materials
[14C]-Serine (164mCi/mmol) was purchased from Perkin
Elmer. Anti-glutathione (anti-SSG) antibody was from
Virogen. Thiostar (thiol fluorescent detection reagent) was
purchased from Arbor Assays. BioGEE and streptavidin-
agarose were purchased from Invitrogen. All other chemicals
were purchased from Sigma or Fisher.
Protein purification
The pGEX4T-1-C346S and pGEX4T-1-C272A/C275S
plasmid constructs for expressing mutant CBS were gener-
ated by site-directed mutagenesis using the Quikchange II XL
site-directed mutagenesis kit (Agilent) with the following
mutagenic primers and the corresponding antisense primers
containing the opposite sequence:
Cys346Ser: 5¢-GCAAGAGGGGCTGCTGAGCGGTGG-
CAGTGCTGGCAG-3¢
Cys272Ala: 5¢-CAGGAAGCTGAAGGAGAAGGCTCC-
TGGATGCAGGATCATTG-3¢
Cys275Ser: 5¢-GAAGGAGAAGGCTCCTGGAAGCAG-
GATCATTGGGGTGG-3¢
Mutation was confirmed by nucleotide sequence determi-
nation at the DNA Sequencing Core Facility (University of
Michigan, Ann Arbor).
Wild-type and mutant CBSs were expressed and purified
as previously described (49) with the exception that the
Cys346Ser mutant was induced in the presence of 3% eth-
anol to promote correct protein folding (28). In brief, cells
obtained from a 6-L culture were resuspended in 500ml of
1 · phosphate-buffered saline (PBS); supplemented with
10mM b-mercaptoethanol, 10mg PLP, 50mg of lysozyme,
and a protease inhibitor cocktail tablet (from Roche Diag-
nostics). The cells were lysed by sonication, and the su-
pernatant was obtained by centrifugation at 15,000 g for
30min. The supernatant was loaded onto a Glutathione
Sepharose 4B column, which was pre-equilibrated with
1 · PBS. The column was washed with 1 · PBS, and gluta-
thione S-transferase (GST)-fused CBS was eluted with
50mM Tris, pH 8.0 in the presence of 10mM GSH. The
GST-fused CBS was cleaved with thrombin at 4C at a final
concentration of 2 U/mg protein, and the GST tag was re-
moved on a Q sepharose column (2.5 · 12 cm) equilibrated
with 50mM Tris buffer, pH 8.0, and then washed with the
same buffer. The protein was eluted with a 500ml gradient
ranging from 0 to 500mMNaCl in 50mM Tris-HCl, pH 8.0.
The fractions of interest were dialyzed, concentrated, and
stored at - 80C.
S-glutathionylation of CBS in vitro
Purified CBS (0.5mg/ml) protein was treated with 1mM
diamide and 1.5mM GSH in Buffer A (50mM Tris-HCl,
pH 8.0) at room temperature for 30min. After this reac-
tion, where indicated, 10mM DTT was added for 30min at
room temperature to induce deglutathionylation and
the samples were analyzed using Western blotting. For
S-glutathionylation by disulfide exchange with GSSG, re-
combinant CBS (0.5mg/ml) protein was incubated for
120min with 1–5mM GSSG at room temperature in Buffer
A. For S-glutathionylation with H2O2, purified CBS (0.5mg/
ml) protein was treated with 10–200lM H2O2 at room tem-
perature for 30min and then, 50–1000lM GSH (i.e., five
equivalents relative to H2O2) was added to the reaction mix-
ture for 30min.
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Determination of the fraction of S-glutathionylated CBS
Titration of free thiol groups with DTNB. Purified wild-
type CBS was treated with 10mM DTT for 30min at room
temperature, and then DTT was removed using a concen-
trator and washed with 50mM Tris-HCl, pH 8.0 with six
buffer exchanges. For the preparation of S-glutathionylated
proteins, CBS was treated with 1mM diamide and 1.5mM
GSH in Buffer A at room temperature for 30min, followed by
ultrafiltration using a 1ml spin column.
To examine the number of free thiol groups in CBS, the
unmodified and modified CBS (5 lM) was titrated with
0.5mM DTNB. Control samples contained the same amount
of DTNB in the same buffer but were devoid of CBS protein.
The final mixtures (200ll) were incubated for 10min at room
temperature, and the samples were analyzed spectrophoto-
metrically at 412 nm using an extinction coefficient of 13,600
M - 1 cm - 1 (40).
Separation of S-glutathionylated CBS using streptavidin-
agarose resin. Purified CBS was treated with 1mM di-
amide and 1.5mM BioGEE at room temperature for 30min,
after which excess diamide and BioGEE were completely
removed using ultrafiltration tubes and 1· PBS buffer. Then,
100 ll CBS (0.5mg/ml) was added to 100ll streptavidin-
agarose resin pre-equilibrated with 1· PBS buffer and in-
cubated with gentle rotation for 30min at room temperature.
The streptavidin-agarose resin bound glutathionylated CBS
and was centrifuged at 1000 g for 5min. The protein con-
centration of the supernatant was measured using the Brad-
ford reagent to estimate the proportion of S-glutathionylated
CBS. Control reactions in which CBS (0.5mg/ml) was not
treated with diamide and BioGEE were prepared in parallel.
For S-glutathionylation with H2O2, purified CBS (0.5mg/
ml) protein was treated with 25lM H2O2 at room tempera-
ture for 30min and then 125 lM BioGEE was added to the
reaction mixture for 30min. Excess H2O2 and BioGEE were
removed using ultrafiltration tubes and washed with 1 · PBS
buffer, and the samples were processed as described earlier.
Control reactions in which CBS (0.5mg/ml) was not treated
with H2O2 and BioGEE were prepared in parallel.
CBS assay
Enzyme activity was measured using [14C]-serine as pre-
viously described (49). Briefly, the 200ll assay mixture
contained 100mM HEPES, pH 7.4, 0.25mM PLP, 0.5mg/ml
bovine serum albumin, 30mM [14C]-serine (*40,000 dpm),
and 20mM l-homocysteine. The reaction mixture was in-
cubated at 37C for 5min, and the reaction was started by the
addition of 5.0 lg of purified CBS. After 30min, the reaction
was terminated by the addition of 200ll of 10% tri-
fluoroacetic acid. AdoMet (1mM final concentration) was
added to the reaction mixture during the preincubation
when indicated. One unit of CBS catalyzes the formation of
1 lmol of cystathionine in 1 h at 37C under standard assay
conditions.
H2S production assays
H2S generation using l-cysteine and l-homocysteine as
substrates was measured as previously described (7). The
reaction mixture containing 100mM HEPES buffer, pH 7.4,
0.4mM lead nitrate, 25mM l-homocysteine, and CBS was
preincubated at 37C for 3min and the reaction was started
by the addition of 25mM l-cysteine. For testing the effect of
AdoMet, 1mM AdoMet (final concentration) was added to
the reaction mixture along with cysteine. An extinction co-
efficient of 5500 M- 1 cm - 1 at 390 nm was used for estima-
tion of the lead sulfide concentration.
Activity assay for S-glutathionylated CBS in vitro
The activity of S-glutathionylated CBS was measured
using methylcysteine as substrate. Before the start of the
assay, S-glutathionylated CBS was centrifuged using a
Centricon concentrator to change the buffer using a 1ml spin
column. The reaction mixture containing 100mM HEPES
buffer, pH 7.4, 10mM methylcysteine, and 50lmol Thiostar
thiol fluorescent detection reagent was added to a 96-well
plate, and the reaction was started by the addition of 15 lg of
CBS. The 96-well plate was placed in a multifunctional mi-
croplate reader, and the kinetics of the enzyme-catalyzed
reaction was studied. An excitation wavelength of 400 nm
and an emission wavelength of 515 nm were set for mea-
suring the production of the thiol adduct between CH3SH and
Thiostar. The activity of unmodified wild-type CBS was set
at 100%. Alternatively, DTNB was used in the reaction
mixture to detect formation of methanethiol using an ex-
tinction coefficient of 13,600 M- 1 cm - 1 (40).
Western blot analysis
Proteins were blotted onto a polyvinylidenedifluoride
membrane, incubated with anti-CBS or anti-SSG primary
antibody at 4C overnight, and then reacted with horseradish-
peroxidase-conjugated secondary antibodies for 1 h. Signals
were visualized by enhanced chemiluminescence plus re-
agents.
LC-MS/MS analysis
A 50ll solution of CBS (100lM) was reacted with 2mM
diamide and 3mM GSH for 30min at room temperature.
Untreated CBS was used as a control. The samples were
dialyzed against 200mM Tris-HCl buffer (pH 8.0) and then
denatured using 6 M guanidine hydrochloride. At the end of
the experiments, the free thiol groups of samples were deri-
vatized with iodoacetamide at a final concentration of 10mM.
The samples were concentrated using a 1ml Centricon col-
umns, diluted 10-fold with ammonium bicarbonate buffer pH
8.0, and then digested using a protein:trypsin ratio of 20:1 at
37C for 12 h. The digested samples were acidified with 10%
formic and directly used for LC-MS/MS analyses.
All analyses were carried out using an Agilent 1200 Series
HPLC, ACE 5 C18-300 column (2.1 · 100mm) at a flow rate
of 0.1ml/min, and the injection volume was 6 ll. Mobile
phase A and B consisted of 0.1% formic acid in H2O and
0.1% formic acid in acetonitrile, respectively. Separation
of peptides was achieved using the following gradient:
t = 0min: 5% B; t= 1min: 5% B; t= 2min: 5% B; t= 10min:
15% B; t = 38min: 40% B; t = 43min: 100% B; t= 44min:
100% B; t = 45min: 5% B; and t = 60min: 5% B (column re-
equilibration). A high-performance liquid chromatography
(HPLC) system was directly coupled to a BrukerSoalrix 70
Hybrid FTMS instrument equipped with an electrospray
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ionization source. The system was controlled by HyS-
tarv.3.4.8.0 software (BrukerDaltonics). MS data were col-
lected with a resolving power of 110,000 (at m/z 400) in a
positive mode using the following conditions: a capillary
voltage of 4500V and an end plate offset of - 500V. The dry
temperature was set at 180C. Dry gas flow was maintained at
4L/min. Acquisition range was 344–2200 m/z with 0.4 s ion
accumulation time. For MS/MS analysis, automated MS/MS
spectra were acquired during the run in the data-dependent
acquisition MS/MS boost mode with the selection of the most
abundant precursor ion and CID fragmentation. Data were
deconvoluted and a peak list created by DataAnalysisv.4.0
software (BrukerDaltonics). MS/MS search was performed
against the amino-acid sequence of the CBS protein with a
mass tolerance of 30ppm for both the precursor ions and the
fragment ions using BioToolsv3.2 software (BrukerDaltonics).
Cell culture and preparation of cell lysates
Human embryonic kidney cells, HEK293, were grown in
Dulbecco’s modified Eagle’s medium containing 10% (v/v)
fetal bovine serum, 100U/ml penicillin, and 100 lg/ml
streptomycin. Cells were grown at 37C in an atmosphere of
5% CO2 and 95% air and grown to 80%–90% confluence in
six-well plates. To generate whole cell extracts, cells were
rinsed thrice with ice-cold PBS and then lysed in RIPA buffer
(50mM Tris-Cl pH 7.4, 1% NP-40, 150mM NaCl, 1mM
EDTA, 1mM PMSF, and a protease inhibitor cocktail tablet/
50ml). After centrifugation at 12,000 g for 10min, the su-
pernatant was collected and the protein concentration was
determined by the Bradford method.
Streptavidin pull-down assay
HEK293 cells were preincubated with 250lM BioGEE, a
membrane-permeable analogue of GSH (13) for 1 h, and
subsequently exposed to 200lMH2O2 for 10, 30, and 60min.
Biotin-bound proteins were extracted using streptavidin af-
finity resin and eluted with 10mM DTT. The eluent was
subjected to nonreducing SDS-PAGE and probed with an
antibody that was specific to CBS. Cells were incubated
without BioGEE and served as a control. An equal amount of
total whole cell extract (10 lg) at the designated time point
was then subjected to nonreducing SDS-PAGE and probed
with antibodies that were specific to CBS.
Streptavidin-agarose beads were used to pull down the
biotinylated GSH-conjugated proteins. Briefly, before the
immobilization, the beads were washed thrice with RIPA
buffer to remove preservatives. Equal amounts of protein
samples from HEK293 cells treated with H2O2 for different
time periods were then mixed with 20ll of beads, and the
mixture was incubated at room temperature with gentle rota-
tion for 30min. The bead-protein complex was separated, and
the pellet containing labeled proteins was re-suspended in
RIPA buffer, followed by three washes with RIPA buffer.
Finally, proteins bound to streptavidin via a mixed disulfide
bondwere eluted from the beads by incubation for 30min with
50mM Tris-Cl pH 7.4 containing 0.1% SDS and 10mMDTT.
Proteins in the eluent were detected by Western blotting.
Activity assay of S-glutathionylated CBS in cell lysates
HEK293 cells treated with 200lMH2O2 for different time
periods were washed thrice with ice-cold PBS buffer and then
scraped from 100mm plates. The harvested cells were
transferred to 1.5ml centrifuge tubes and centrifuged for
5min. The supernatant was carefully discarded, and the pellet
was weighed. HEPES buffer (100mM, pH 7.4) was added to
the tube (15 ll buffer/1mg cell pellet), and the cell suspen-
sion was frozen and thawed thrice using an acetone/dry ice
bath. HEK293 cells that were not treated with H2O2 served as
a control.
The reaction mixtures (500 ll) containing 100mMHEPES
buffer pH 7.4, cell lysate (400ll), 10mM methylcysteine,
and 2.5mM PPG, an inhibitor of CSE, were prepared in
polypropylene syringes, as previously described (22). Syr-
inges were sealed with plungers and made anaerobic by
flushing the headspace with nitrogen five times using a three-
way stopcock, and then left under nitrogen in a final total
volume of 5ml. Syringes were placed in an incubator at 37C
with gentle shaking (75 rpm) for 20min. Control reactions in
which buffer replaced the cell lysate were prepared in par-
allel. Aliquots of 0.1–0.3ml from the gas phase of the reac-
tion syringes were collected using gas-tight syringes inserted
through a septum attached to the stopcock, and injected in an
HP 6890 gas chromatograph (Hewlett Packard) that was
equipped with a DB-1 column (30m· 0.53mm · 1.0 lm) as
previously described (53). Helium was used as the carrier gas
at a flow rate of 1ml/min, and a temperature gradient ranging
from 30C to 110C over a 20min period was used. Metha-
nethiol was detected using a 355 sulfur chemiluminescence
detector (Agilent). A methanethiol standard was obtained
from Cryogenic Gases. An internal standard of dimethyl
sulfide was added to the reaction mixtures.
Statistical analysis
Data from experiments were expressed as mean – SD.
Student’s t-test was used, where appropriate, for comparing
the mean values between control and tested groups. Statis-
tical significance was considered at p < 0.05.
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Abbreviations Used
AdoMet¼ S-adenosylmethionine
BioGEE¼ biotinylated glutathione ethyl ester
CBS¼ cystathionine b-synthase
CSE¼ cystathionine c-lyase
DA¼ diamide
DTNB¼ 5,5¢-dithiobis-2-nitrobenzoic acid
DTT¼ dithiothreitol
GCL¼ c-glutamylcysteine ligase
GP¼ glutathione peroxidase
GSH¼ glutathione
GSSG¼ glutathione disulfide
GST¼ glutathione S-transferase
HPLC¼ high performance liquid
chromatography
LC-MS/MS¼ liquid chromatography–tandem
mass spectrometry
PBS¼ phosphate-buffered saline
PLP¼ pyridoxal 5¢-phosphate
PPG¼ propargylglycine
SDS-PAGE¼ sodium dodecyl sulfate–polyacrylamide
gel electrophoresis
tBuOOH¼ tertiary butyl hydroperoxide
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